The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Open accessAbstract
BACKGROUND: Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers. Neonatal infection has high morbidity and mortality. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. The global burden of HSV-2 infection was last estimated for 2003. Here we present new global estimates for 2012 of the burden of prevalent (existing) and incident (new) HSV-2 infection among females and males aged 15-49 years, using updated methodology to adjust for test performance and estimate by World Health Organization (WHO) region. METHODS AND FINDINGS: We conducted a literature review of HSV-2 prevalence studies world-wide since 2000. We then fitted a model with constant HSV-2 incidence by age to pooled HSV-2 prevalence values by age and sex. Prevalence values were adjusted for test sensitivity and specificity. The model estimated prevalence and incidence by sex for each WHO region to obtain global burden estimates. Uncertainty bounds were computed by refitting the model to reflect the variation in the underlying prevalence data. In 2012, we estimate that there were 417 million people aged 15-49 years (range: 274-678 million) living with HSV-2 infection world-wide (11.3% global prevalence), of whom 267 million were women. We also estimate that in 2012, 19.2 million (range: 13.0-28.6 million) individuals aged 15-49 years were newly-infected (0.5% of all individuals globally). The highest burden was in Africa. However, despite lower prevalence, South-East Asia and Western Pacific regions also contributed large numbers to the global totals because of large population sizes. CONCLUSIONS: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., vanCott, T., & Quinn, T. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04331-2 · Cited by 1,281
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E. (2006) · JAMA · doi:10.1001/jama.296.8.964 · Cited by 1,035
Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
Smith, J. S., & Robinson, N. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/343739 · Cited by 885
The Acquisition of Herpes Simplex Virus during Pregnancy
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 782
Mercer, C. H., Tanton, C., Prah, P., Erens, B., Sonnenberg, P., Clifton, S., Macdowall, W., Lewis, R., Field, N., Datta, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62035-8 · Cited by 724 · cited 1×
“This is likely a consequence of decreases in childhood oral HSV-1 infection and hence lowered childhood-acquired HSV-1 immunity [37], together with an increase in rates of oral sex following sexual maturity [47].”
BackgroundOnce-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035144 · Cited by 720
Wald, A., & Link, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338231 · Cited by 691
Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., & Corey, L. (2003) · JAMA · doi:10.1001/jama.289.2.203 · Cited by 679
Gupta, R., Warren, T., & Wald, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61908-4 · Cited by 599
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904849 · Cited by 524
Self-citationEfficacy Results of a Trial of a Herpes Simplex Vaccine
Belshe, R. B., Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. A., Ewell, M. G., Stokes-Riner, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103151 · Cited by 510
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Looker, K. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.046128 · Cited by 493
Self-citationGlynn, J. R., Caraël, M., Auvert, B., Kahindo, M., Chege, J., Musonda, R., Kaona, F., & Buvé, A. (2001) · AIDS · doi:10.1097/00002030-200108004-00006 · Cited by 451
Celum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., Cowan, F., Casapia, M., Ortiz, A., Fuchs, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60920-4 · Cited by 449
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
Benedetti, J., Corey, L., & Ashley, R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00004 · Cited by 428
Roberts, C. M., Pfister, J. R., & Spear, S. J. (2003) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000092387.58746.c7 · Cited by 379
Effect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania
Watson-Jones, D., Weiss, H. A., Rusizoka, M., Changalucha, J., Baisley, K., Mugeye, K., Tanton, C., Ross, D., Everett, D., Clayton, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800260 · Cited by 371
Catalytic Models in Epidemiology
Muench, H. (1959) · Harvard University Press eBooks · doi:10.4159/harvard.9780674428928 · Cited by 268
Schacker, T., Zeh, J., Hu, H., Hill, E., & Corey, L. (1998) · The Journal of Infectious Diseases · doi:10.1086/314486 · Cited by 236
Increased Genital Shedding of Herpes Simplex Virus Type 2 in HIV-Seropositive Women
Augenbraun, M., Feldman, J., Chirgwin, K., Zenilman, J., Clarke, L., DeHovitz, J., Landesman, S., & Minkoff, H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00006 · Cited by 221
Serological Testing for Herpes Simplex Virus (HSV)–1 and HSV‐2 Infection
Wald, A., & Ashley‐Morrow, R. (2002) · Clinical Infectious Diseases · doi:10.1086/342104 · Cited by 207
Reynolds, S. J., Risbud, A. R., Shepherd, M. E., Zenilman, J. M., Brookmeyer, R. S., Paranjape, R. S., Divekar, A. D., Gangakhedkar, R. R., Ghate, M. V., Bollinger, R. C., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/368357 · Cited by 206
(2010) · PsycEXTRA Dataset · doi:10.1037/e552402010-003 · Cited by 203
Sorting out the new HSV type specific antibody tests
Ashley, R. L. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.4.232 · Cited by 171
Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., & Corey, L. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000070126.90718.7b · Cited by 159
Lingappa, J. R., Baeten, J. M., Wald, A., Hughes, J. P., Thomas, K. K., Mujugira, A., Mugo, N., Bukusi, E. A., Cohen, C. R., Katabira, E. T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62038-9 · Cited by 152
Self-citationMorrow, R. A., Nollkamper, J., Robinson, N. J., Bishop, N., & Smith, J. S. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00836.x · Cited by 140
Ryder, N., Jin, F., McNulty, A. M., et al. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2008.033902 · Cited by 118
Kaushic, C., Roth, K., Anipindi, V. C., & Xiu, F. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.12.004 · Cited by 115
Morrow, R. A., Krantz, E. M., & Wald, A. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200304000-00007 · Cited by 100
Brown, J., Wald, A., Hubbard, A., Rungruengthanakit, K., Chipato, T., Rugpao, S., Mmiro, F. A., Celentano, D. D., Salata, R., MORRISON, C. S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282004929 · Cited by 99
Current status and prospects for development of an HSV vaccine
Johnston, C., Koelle, D. M., & Wald, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.066 · Cited by 81
Maternal and Neonatal Herpes Simplex Virus Infections
Pinninti, S. G., & Kimberlin, D. W. (2013) · American Journal of Perinatology · doi:10.1055/s-0032-1332802 · Cited by 80
Abu-Raddad, L. J., Schiffer, J. T., Ashley, R. L., Mumtaz, G. R., Alsallaq, R. A., Akala, F. A., Semini, I., Riedner, G., & Wilson, D. (2010) · Epidemics · doi:10.1016/j.epidem.2010.08.003 · Cited by 75
Morrow, R. A., & Friedrich, D. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01370.x · Cited by 64
Ashley, R. L., Eagleton, M., & Pfeiffer, N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1632-1633.1999 · Cited by 56
Vaccines against sexually transmitted infections: The way forward
Broutet, N. J. N., Fruth, U., Deal, C. D., Gottlieb, S. L., & Rees, H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.053 · Cited by 44
Self-citationTassiopoulos, K., Seage, G. R., Sam, N., Kiwelu, I., Shao, J. F., Ao, T. T.-H., Essex, M., COPLAN, P. M., Rosenberg, Z., Hughes, M., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/510537 · Cited by 37
Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency
Kenyon, C. R., Colebunders, R., & Hens, N. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472816 · Cited by 27
Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland
Tuokko, H., Bloigu, R., & Hukkanen, V. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051453 · Cited by 21
Research works printed but not linked: 5
- J Todd, 2013, Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania, PLoS One, 8, e59037, 10.1371/journal.pone.0059037 · doi:10.1371/journal.pone.0059037
- Kelsey JL, Thompson WD, Evans AS (1986) Methods in Observational Epidemiology (Monographs in Epidemiology & Biostatistics): Oxford University Press.
- Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit J, et al. (2008) Sexually Transmitted Diseases; Chapter 24: Genital Herpes: McGraw-Hill Medical.
- KC Pena, 2010, Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States, J Clin Microbiol, 48, 150, 10.1128/JCM.01336-09 · doi:10.1128/jcm.01336-09
- E Gray, 2008, Herpes simplex type 1 versus Herpes simplex type 2 in anogenital herpes; a 10 year study from the Waikato region of New Zealand, N Z Med J, 121, 43
Cited by
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
James, C., Harfouche, M., Welton, N. J., Turner, K. M., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.19.237149 · Cited by 791
Self-citationLooker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140765 · Cited by 644
Self-citationLooker, K. J., Elmes, J. A. R., Gottlieb, S. L., Schiffer, J. T., Vickerman, P., Turner, K. M. E., & Boily, M.-C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30405-x · Cited by 300
Self-citationTorrone, E. A., Morrison, C. S., Chen, P.-L., Kwok, C., Francis, S. C., Hayes, R. J., Looker, K. J., McCormack, S., McGrath, N., van de Wijgert, J. H. H. M., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002511 · Cited by 256
Self-citationTenofovir gel for the prevention of herpes simplex virus Type 2 infection.
Abdool Karim, S. S., Abdool Karim, Q., Kharsany, A. B. M., Baxter, C., Grobler, A. C., Werner, L., Kashuba, A., Mansoor, L. E., Samsunder, N., Mindel, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410649 · Cited by 92
Metadata
- Authors
- Looker, K. J., Magaret, A. S., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-01-21
- Volume
- 10
- Issue
- 1
- Pages
- e114989
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2070423053
- Cited by
- 519
- References
- 42
- FWCI
- 40.82
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-05-20)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.